InvestorsHub Logo
Followers 10
Posts 1456
Boards Moderated 0
Alias Born 08/02/2010

Re: Altitrade Partners post# 6777

Friday, 11/09/2018 3:06:06 PM

Friday, November 09, 2018 3:06:06 PM

Post# of 11429


Which makes this an opportune time to get long, imo, for several reasons.

There's unlikely to be another Willis "disaster" in the near term; certainly, not another equity raise, nor financing mess up.

We knew there would be this raise coming, as it does indeed provide the company a whole lot more flexibility, especially if they are in position for large launches, supported by marketing.

The problem with this raise is that it was a low price, likely because it's premature imo. The price is not that surprising; of course it will be at a discount to market, particularly a market price that isn't (yet??) supported by its balance sheet. The "good" news is that the share price now is at the "discounted level,' which I believe provides something of a put not too far below these levels, as long as the company doesn't mess up operations.

After this dilution is absorbed and understood, which should begin next week, concentration will be on the future, the main components/catalysts of which are: fully funded balance sheet, guided profitability in Q4, and significant ramps for NHanced and CBD products in (early?) 2019, pus intermittent marijuana stock mania.